| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |